English

This video educates viewers on what the PrEP-to-Need Ratio is and how to properly use it to evaluate health equity.

This video walks through AIDSVu Location Profiles -- interactive, user-friendly summaries of HIV data for various locations across the U.S., including cities, counties, states, and regions. These profiles provide insights into HIV prevalence, new diagnoses, mortality, and more, helping users understand the impact of HIV in their communities.

This webinar recording discusses how the hepatitis A landscape is changing globally. Between 2010 and 2019, the number of deaths from hepatitis A decreased globally by 10%, despite the number of cases increasing by 4%. A number of factors have helped drive these changes, including globalization and increased hepatitis A vaccination rates. 

This toolkit is organized into flexible, standalone sections to meet the varied needs of Title X and SRH providers. You do not need to use the toolkit in order. The toolkit is organized by types of PrEP services so that the user can identify and access the tools and resources most relevant to the services provided in their setting. Whether you provide counseling and referrals or deliver the full spectrum of services onsite, the materials here are designed to support your work.

This webinar recording explores two critical public health topics: congenital syphilis and heat-related illnesses. Presenters provide an overview of current trends, prevention strategies, and treatment considerations for congenital syphilis, alongside guidance on recognizing, preventing, and managing heat injuries. The session offers practical insights for healthcare providers, public health professionals, and community partners working to address these urgent health concerns.

This webinar recording discusses tests for TB and drug resistance. It also reviews TB screening, diagnosis, treatment monitoring, and more. 

This webpage outlines the importance of disaster preparedness for people with HIV. Natural disasters—such as hurricanes, tornadoes, tsunamis, and wildfires—can displace anyone, disrupting access to critical HIV medicines and care. It emphasizes the need for individuals with HIV to plan ahead to maintain treatment continuity, protect their health, and reduce the risk of transmission, including steps to connect with new healthcare providers if displaced.

This fact sheet discusses that navigating prescription drug access for clients can present many challenges and barriers. NASTAD is committed to developing and maintaining resources highlighting initiatives aiming to maximize affordable access to essential medicines, including programs for uninsured/underinsured individuals and cost-sharing assistance for insured individuals contending with out-of-pocket spending.

This webpage explain how LGBTQ+ young people are not inherently prone to suicide risk because of their sexual orientation or gender identity but rather placed at higher risk because of how they are mistreated and stigmatized in society.

This counseling guide summarizes recommendations from the U.S. Department of Health and Human Services Panel on Treatment of HIV During Pregnancy and Prevention of Perinatal Transmission regarding the use of antiretroviral (ARV) drugs during pregnancy or when trying to conceive. Its purpose is to support informed, shared decision-making for individuals living with HIV and their clinicians. Effective antiretroviral therapy (ART) with sustained viral suppression is the cornerstone of maternal health and prevention of perinatal HIV transmission.